dc.identifier.citation |
Alfonso, V.; Flichman, D.; Sookoian, S.; Mbayed, V. A.; Campos, R. H.; 2001: Phylogenetic characterization of genotype 4 hepatitis C virus isolates from Argentina. J. Clin. Microbiol. 39, 5:1989-92. Altschul, S.F.; Madden, T.L.; Schäffer, A.A.; Zhang, J.; Zhang, Z.; Miller, W.; Lipman, D.J.; 1997: Gapped BLAST nad PSIBLAST: a new generation of protein database search programs. Nucl. Acids Res., 25:3389-402. Bartenschlager, R.; 1997: Molecular targets in inhibition of hepatitis C virus replication. Antivir. Chem. Chemother. 8:281-301. Bukh, J.; Miller, R.H.; Purcell, R.H.; 1995: Defining the genotypes of hepatitis C virus and their epidemiology. INTER-action 3:10-15. Cheng, J.; Zhong, Y.; Liu, Y.; Dong, J., Yang, J.; Yang, S.; 2002: Inducible expression of nonstructural protein 3 of hepatitis C virus in E. coli. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, 16, 1:85-7. De Francesco, R.; Steinkühler, C.; 2000: Structure and function of the hepatitis C virus NS3-NS4A serine proteinase. Curr. Top. Microbiol. Immunol. 242:149-69. Du, G.X.; Hou, L.H.; Guan, R.B.; Tong, Y.G.; Wang, H.T.; 2002: Establishment of a simple assay in vitro for hepatitis C virus NS3 serine protease based on recombinant substrate and single-chain protease. Wld. J Gastroenterol. 8, 6:1088-93. Dusheiko, G.; Weiss, H.; Brown, D.; McOmish, F.; Yap, P.L.; et al.; 1994: Hepatitis C virus genotypes: an investigation of typespecific differences in geographic origin and disease. Hepatol., 19:13- 8. Frick, D.N.; 2007: The hepatitis C virus NS3 protein: a model RNA helicase and potential drug target: Review. Mol. Biol., 9, 1:1-20. Hong, Z.; Standring, D.N.; Baroudy, B.; Lau, J.Y.; 2000: Development of novel anti-HCV therapies: HCV protease, helicase, and polymerase as thera-peutic targets. Acta Gastroenterol. Belgica, 63:210-2. Jiao, X.; Wang, R.Y.; Feng, Z.; Hu, G.; Alter, H.J.; Shih, J.; 2004: DNA immunization encoding the secreted nonstructural protein 3 (NS3) of hepatitis C virus and enhancing the Th1 type immune response. J. Viral. Hepat. 11, 1:18-26. Johnson, D.R.; Bhatnagar, R.S; Knoll, L.J.; Gordon, J.I.; 1994: Genetic and biochemical studies of protein N-myristoylation. Ann. Rev. Biochem., 63: 869-914. Kwong, A.D.; Kim, J.L.; Rao, G.; Lipovsek, D.; Raybuck, S.; 1998: He-patitis C virus NS3/4A protease. Antivir. Res. 40:1-18. Lavanchy, D.; McMahon, B.; 2000: Worldwide Prevalence and Prevention of HC. In: Hepatitis C. By Liang TJ, Hoofnagle JH, San Diego, Academic Press. Lodrini, S.; Bagaglio, S.; Canducci, F.; De Mitri, M.; Andreone, P.; et al.; 2003: Sequence analysis of NS3 protease gene in clinical strains of hepatitis C virus. J. Biol. Regul. Homeost. Agents 17, 2:198-204. Misialek, S.; Rajagopalan, R.; Stevens, S.K.; Beigelman, L.; Seiwert, S.D.; Kossen, K.; 2009: Optimization of the multiple enzymatic activities of the hepatitis C virus NS3 protein. Anal. Biochem., 394,1:138-40. Penin, F.; Dubuisson, J.; Rey, F. A.; Moradpour, D.; Pawlotsky, J. M.; 2004: Structural biology of hepatitis C virus. Hepatol., 39, 1:5-19. Pless, D.D.; Lennarz, W. J.; 1977: Enzymatic conversion of proteins to glycoproteins. Proc. Natl. Acad. Sci. USA., 74, 1:134-8. Poliakov A.; Hubatsch I.; Shuman C.F.; Stenberg G.; Danielson U. H.; 2002: Expression and purification of recombinant full-length NS3 protease-helicase from a new variant of Hepatitis C virus. Protein Exp. Purif., 25, 3: 363-71. Ray, S.C.; Arthur, R.R.; Carella, A.; Bukh, J.; Thomas, D.L.; 2000: Genetic epidemiology of hepatitis C virus throughout Egypt. J. Infect. Dis., 182: 698-707. Sambrook, J.; Fritsch, E.F.; Maniatis, T.; 1989: Molecular Cloning: Cold Spring Harbor Laboratory Press. Sillanpää, M. ; Melén, K.; Porkka, P.; Fagerlund, R.; Nevalainen, K.; et al.; 2009 : HCV core, NS3, NS4B and NS5A are the major immunegenic proteins in humoral immunity in chronic HCV infection. Virol. J., 24, 6:86. Stuyver, L.; Van Arnhem, W.; Wyseur, A.; Hernandez, F.; Delaporte, E.; Maertens, G.; 1994: Classification of hepatitis C viruses based on phylo-genetic analysis of the envelope 1 and nonstructural 5B regions and identi-fication of five additional subtypes. Proc. Natl. Acad. Sci. USA, 91, 10:104-13. Tai, C.L.; Chen, D.S.; Hwang, L.H.; 1996: The helicase activity associated with hepatitis C virus nonstructural protein 3 (NS3). J. Virol., 70:8477-84. Tanaka, T.; Tsukiyama, K.; Yamaguchi, K.; Yagi, S.; Tanaka, S.; et al.; 1994: Significance of specific antibody assay for genotyping of hepatitis C virus. Hepatol., 19, 6:1347-53. Tellinghuisen, T.L.; Rice, C.M.; 2002: Interaction between hepatitis C virus proteins and host cell factors. Curr Opin Microbiol., 5:419- 27. Thibeault, D.; Bousquet, C.; Gingras, R.; Lagace, L.; Maurice, R.; et al.; 2004: Sensitivity of NS3 serine proteases from hepatitis C virus genotypes 2 and 3 to the inhibitor BILN 2061. J. Virol., 78, 14:7352- 9. Vishnuvardhan, D.; Kakiuchi, N.; Urvil, P.T.; Shimotohno, K.; Kumar, P.; Nishikawa, S.; 1997: Expression of highly active recombinant NS3 protease domain of hepatitis C virus in E. coli. FEBS Letters, 402, 2-3:209-12. |
en_US |